KCM Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,612
Closed -$259K 344
2019
Q3
$259K Hold
2,612
0.02% 297
2019
Q2
$241K Sell
2,612
-367
-12% -$34.9K 0.01% 299
2019
Q1
$281K Sell
2,979
-150
-5% -$13.1K 0.02% 280
2018
Q4
$201K Sell
3,129
-170
-5% -$12.5K 0.01% 473
2018
Q3
$295K Buy
3,299
+285
+9% +$25.2K 0.02% 438
2018
Q2
$239K Sell
3,014
-289
-9% -$24K 0.01% 469
2018
Q1
$295K Sell
3,303
-381
-10% -$36.6K 0.02% 441
2017
Q4
$384K Sell
3,684
-1,669
-31% -$188K 0.02% 394
2017
Q3
$781K Sell
5,353
-1,049
-16% -$143K 0.05% 287
2017
Q2
$831K Sell
6,402
-70
-1% -$8.58K 0.05% 271
2017
Q1
$805K Hold
6,472
0.05% 284
2016
Q4
$749K Hold
6,472
0.05% 288
2016
Q3
$677K Sell
6,472
-126
-2% -$13.6K 0.05% 309
2016
Q2
$651K Buy
6,598
+162
+3% +$16.8K 0.05% 305
2016
Q1
$644K Sell
6,436
-320
-5% -$33K 0.05% 301
2015
Q4
$809K Buy
6,756
+527
+8% +$61K 0.06% 262
2015
Q3
$674K Sell
6,229
-828
-12% -$103K 0.06% 294
2015
Q2
$817K Buy
7,057
+2,012
+40% +$230K 0.07% 272
2015
Q1
$582K Buy
5,045
+62
+1% +$7.41K 0.05% 323
2014
Q4
$557K Sell
4,983
-110
-2% -$11.6K 0.05% 323
2014
Q3
$483K Sell
5,093
-771
-13% -$69.6K 0.04% 330
2014
Q2
$504K Buy
5,864
+658
+13% +$50K 0.05% 312
2014
Q1
$363K Sell
5,206
-396
-7% -$31.4K 0.04% 347
2013
Q4
$473K Sell
5,602
-242
-4% -$19.1K 0.05% 291
2013
Q3
$450K Sell
5,844
-1,790
-23% -$125K 0.05% 296
2013
Q2
$447K Buy
+7,634
New +$459K 0.05% 298

Other funds holding CELG

KCM Investment Advisors's CELG Position: Q4 2019 in Review

KCM Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,612 shares — an estimated $259K sold.

KCM Investment Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $831K in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • KCM Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • KCM Investment Advisors sold 2,612 Celgene Corp shares in Q4 2019, an estimated $259K.
  • KCM Investment Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • KCM Investment Advisors's Celgene Corp position peaked at $831K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on KCM Investment Advisors's 13F filing for Q4 2019, filed 18 Feb 2020.